“Why the Paralympics/Olympics distinction shouldn’t exist anymore” TEDx talk February 3rd, 2024 (in Italian, for now..)

On February 3rd, 2024, I gave my first TEDx Talk in Forlì, Italy. The theme of the TEDxForlì event (held on February 3rd, 2024 in Forlì, Italy) was “Wishes” (“Desideri”, in Italian) and I talked about “Why the Paralympics/Olympics distinction shouldn’t exist anymore”, or better: why athletes who competed with assistive technologies, such as the Paralympic long-jumper Markus Rehm @the.bladejumper, or the American 400 meter runner Blake Leeper @leepster , should be allowed to compete in the Olympics.

World Athletics current requires athletes who compete with assistive technologies to demonstrate that their assistive technology does not provide them with an unfair advantage over able-bodied athletes.

But, is this rule, fair?

There is no such upper limit on able-bodied athletes to demonstrate that they do not have an unfair advantage over other able-bodied athletes. This upper limits disproportionality restricts athletes with assistive technologies on the basis of the “normal human performance” comparator which is based in the able-bodied athlete. Passé!

Some of you will remember the participation of Oscar Pistorius in the London Olympics in 2012. At that time, Pistorius was allowed to compete on the basis of the 2008 historical award (CAS 2008/A/1480 Pistorius v/ IAAF) of the Court for Arbitration of Sport based in Lausanne, Switzerland.

Why haven’t we seen athletes with assistive technologies compete in the Olympics since then?

Because World Athletics changed its rules though and from 2016 onwards implemented the so-called “Markus Rehm’s rule”, which shifts the burden of proof (of demonstrating absence of advantage) from federation to athlete, and which effectively prohibited any athlete with assistive technology from competing with able-bodied athletes when they start running “too fast”. When they are start being perceiving as a “threat”.

In my TEDx speech I argued that this rule is unfair and discriminatory, and that athletes with assistive technologies should be allowed to compete with “able-bodied” athletes when they meet the qualifying times or qualifying measures for the events.

In the future, there will be no humans as we know them: made only of “flesh”. The future of our species is the cyborg body, the synthetic body, the hybrid body. We should embrace these futures. We shouldn’t fear them. They are the only futures we have.

The recording of the TEDx talk is now available here:

This TEDx was in Italian, as such an opportunity arose, however I am very much looking forward to the opportunity to do a TEDx talk or a TED talk in English about assistive technology, disability and inclusion in sport. For inquiries, contact me at silvia.camporesiATgmail.com

#inclusion #disability #sport #paralympics #markusrehm #blakeleeper #worldathletics #fairness #values #tedxtalks #tedxtalks2024 #publicspeaking #tedtalks

Intervista per Radio Rai Radar FVG “Segnali dalla scienza, dalla cultura, dalla società” andata in onda il 06.02.24 ora disponibile su Rai Play Sound:

La mia intervista per Radio Rai Radar FVG “Segnali dalla scienza, dalla cultura, dalla società” su “Partire (S)vantaggiati: Corpi Bionici e Atleti Geneticamente Modificati”, andata in onda il 06.02.24, ora disponibile su Rai Play Sound a questo link al minuto 40 e 15 secondi:

https://www.raiplaysound.it/audio/2024/02/FVG-ITA-Radar-06022024-802b845d-15de-477e-aa1e-d452d8f76988.html

#radio #intervista #società #cultura #scienza #partiresvantaggiati #fandangolibri

About non-linear academic pathways.

My academic pathway has not always been linear: a graduate of the Collegio Superiore University of Bologna, I obtained my Master’s degree in Medical Biotechnology in 2006 with an experimental thesis in gene therapy at the International Centre for Genetic Engineering and Biotechnology in Triest, under the supervision of Giovanna Cenacchi (University of Bologna), Lorena Zentilin and Mauro Giacca (ICGEB). I then decided to leave the molecular biology bench to train in philosophy of life sciences and ethics in a newly inaugurated (at that time) PhD programme called “Foundations of Life Sciences and Ethics” (Folsatec), a collaboration of the European School of Molecular Medicine and the University of Milano.

I defended my PhD viva in October 2010, with an empirical ethics dissertation investigating the ethical issues of Phase 0 trials in oncology (supervised by Proff Giovanni Boniolo and Gordon McVie).

In October 2010 I also embarked on a new PhD programme in Philosophy of Medicine at King’s College London, funded by a Wellcome Trust fellowship and supervised by Matteo Mameli and David Papineau.

For the 2011/2012 academic year I was a visiting fellow at the Department of Humanities and Social Sciences (formerly known as “Department of Anthropology, History and Social Medicine” or DASHM) at University of California, San Francisco, where I worked with Professor Dorothy Porter and Brian Dolan on ethical issues of gene therapy applied to a variety of settings. I defended my PhD in October 2013 with a thesis titled “From bench to bedside, to track and field: the context of enhancement and its ethical relevance”, which became a book published with UC Medical Humanities Press in 2014.

In October 2013 I successfully applied for a three-year fixed term Lecturer position in Bioethics & Society in the newly established – at that time – department of Social Science, Health and Medicine at King’s College London, chair by the sociologist Nik Rose, who had the vision to launch the first Bioethics & Society programme grounded in social sciences approach and department in the UK. I had the privilege of directing the programme for close to 9 years, with short periods of interruptions due to parental leave. After an accelerated probationary period my position was converted to an open-ended Lecturership position in May 2015. In June 2018 I was promoted to Senior Lecturer and in September 2021 to Reader.

In September 2022, I took the decision to resign from King’s College London. It wasn’t an easy decision however the working conditions had changed for European scholars working in UK academia since Brexit, my department had also shifted its focus away from bioethics towards global health, and it was time for me to leave the UK.

From October 2022 to October 2023, I served as a Senior Research Fellow (Solidarity Fellow) in the Centre for the Study of Contemporary Solidarity at the University of Vienna, where I focused on doing research at the intersection of public health ethics and public policy.

In October 2023, I accepted a 1-year research fellowship position at the University of Bologna working with Raffaella Campaner, Francesco Bianchini and Francesco Guala, on an Italian Ministry of Research funded project on “normative kinds“. In this new role I am enjoying investigating new topics in the philosophy of medicine and science, and enjoying a freedom of doing research.

For the 2023/24 academic year I also hold the position Visiting Professor, Sowerby Project Philosophy of Medicine, Department of Philosophy, King’s College London.

I don’t know what’s going to be my next step, but if you’re reading me and are a PhD student or a junior scholar just starting out in academia, here’s one thing I have learnt form this journey thus far: career pathways and trajectories are often not linear or straightforward, nor are life pathways.

If I have learnt something along the way, is the following: the most important thing is the people you encounter in your trajectory, the connections you make along the way, the network you create.

Keep close to you the people you meet along the ways, the junior and senior colleagues, the students, the admin support staff, the people who serve you coffee at the university café. People are more important than institutions.